肺部作为Risankizumab的副作用之一
Zarif Kazi1, Stuart Jesin1, Samir Ghimire1
1Internal Medicine, Department of Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
European clinical respiratory journal
|January 12, 2026
概括
这一案例凸显了瑞桑基祖马布 (一种生物疗法) 与严重的肺部感染之间的潜在联系. 需要进一步的研究来了解与长期使用瑞桑基祖马布相关的传染风险.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 瑞桑基祖马布是一种长期使用的生物疗法.
- 描述与risankizumab相关的传染性风险至关重要.
- 长期服用瑞桑基祖马布的患者可能面临感染易感性增加.
研究的目的:
- 在接受Risankizumab治疗的患者中报告肺部的病例.
- 调查瑞桑基祖马布与机会性感染之间的潜在关联.
- 为了解瑞桑基祖马布在感染并发症方面的安全性概况作出贡献.
主要方法:
- 一个案例介绍一个30岁的男性患有牛皮和脱发症在Risankizumab.
- 临床表现包括多发性胸痛,咳,血,发烧和肌痛.
- 诊断工作包括CT扫描,唾液AFB培养,多液培养和Xpert MTB/RIF测定.
主要成果:
- 在CT扫描中发现了一个大腔腔病变和多叶膜溢出.
- 传染病检查排除了结核病,但发现了耐甲基黄金葡萄球菌和小鸟菌菌.
- 该患者接受了多西环林治疗,并接受了VATS皮层化.
结论:
- 该案例表明,瑞桑基祖马布与肺部的发展之间可能存在关联.
- 瑞桑基祖马布可能会导致免疫抑制,增加严重感染的风险.
- 这一案例凸显了接受瑞桑基祖马布治疗的患者感染监测的重要性.
相关概念视频
Rheumatic Heart Disease I: Introduction
417
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
417
Drugs for Treatment of Constipation-Predominant IBS
688
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
688
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
476
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
476
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Drugs for Treatment of Ulcerative Colitis in IBD
448
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
448
Inflammatory Bowel Disease II: Crohn's Disease
943
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
943


